Compare the best healthcare stocks, get the most updated comparison by key indicators and discover each stock’s price target as well as recommendations by top Wall Street experts.

Compare up to 10 stocks

Clear

PFE NVS MRK JNJ RHHBY

Comparison Results

PFEPfizer

$42.81

0.02 (0.05%)

$44.36

(3.62% Upside)

$239.64B

18.30

22.63%

2Buy

9Hold

1Sell

Hold

NVSNovartis

$92.39

0.2 (0.22%)

$92.35

(-0.04% Downside)

$206.65B

22.90

11.75%

0Buy

0Hold

1Sell

Moderate Sell

MRKMerck & Company

$76.87

-0.06 (-0.08%)

$93.57

(21.72% Upside)

$194.64B

28.40

5.50%

5Buy

3Hold

0Sell

Moderate Buy

JNJJohnson & Johnson

$172.20

0.02 (0.01%)

$190.86

(10.84% Upside)

$453.31B

25.90

21.25%

7Buy

1Hold

0Sell

Strong Buy

RHHBYRoche Holding

$48.26

0.5 (1.05%)

―

$329.81B

20.40

8.45%

2Buy

0Hold

0Sell

Moderate Buy

Performance Comparison

Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Healthcare Stocks Latest News

Pfizer (PFE) Gets a Hold Rating from Barclays

In a report issued on July 28, Carter Gould from Barclays maintained a Hold rating on Pfizer...

Howard KimJul 30, 2021

PFE

Pfizer (PFE) Gets a Hold Rating from Leerink Partners

Leerink Partners analyst Geoff Porges maintained a Hold rating on Pfizer (PFE – Research Report) today and...

Howard KimJul 29, 2021

PFE

Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Bluebird Bio (BLUE) and BioMarin Pharmaceutical (BMRN)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in...

Ryan AdistJul 29, 2021

JNJ BLUE BMRN

Pfizer Delivers Blowout Quarter, Raises Guidance

Blue-chip pharmaceutical company Pfizer, Inc. (PFE) delivered a blowout second quarter driven by robust COVID-19 vaccine sales. Shares...

Sheryl ShethJul 29, 2021

PFE

Pfizer (PFE) Receives a Hold from Mizuho Securities

Mizuho Securities analyst Vamil Divan maintained a Hold rating on Pfizer (PFE – Research Report) today and...

Christine BrownJul 28, 2021

PFE

JNJ: High-Quality Name at a Solid Valuation

Johnson & Johnson (JNJ) is one of just two AAA-rated companies in the world, the other one being...

Jonathan WeberJul 27, 2021

JNJ

Is Pfizer Fairly Valued?

Pfizer (PFE) stock has been among the under-performers in the last 12 months. Even with the positive tailwinds...

Faisal HumayunJul 25, 2021

PFE

Johnson & Johnson Reports Solid Q2 Results; Ups Guidance

Global pharmaceutical, medical devices and consumer goods conglomerate Johnson & Johnson (JNJ) has reported robust second-quarter 2021 financial...

Richika BiyaniJul 22, 2021

JNJ

Analysts Have Conflicting Sentiments on These Healthcare Companies: Johnson & Johnson (JNJ) and Bluebird Bio (BLUE)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in...

Christine BrownJul 21, 2021

JNJ BLUE

Roche Earnings Preview: Here’s What to Look For

Roche Holding (RHHBY) is scheduled to report second-quarter 2021 earnings on July 22. Switzerland-based Roche Holding Ltd. is...

Shalu SarafJul 21, 2021

RHHBY

Read the latest stock news and analysis from the TipRanks news team.

See All News >

Recent Analysts Ratings of Healthcare Stocks

PFEPfizer Inc

premium

Hold

premium

Reiterated

2021-07-29

MRKMerck & Company

premium

Buy

premium

Reiterated

2021-07-29

NVSNovartis AG

premium

Sell

premium

Reiterated

2021-07-28

JNJJohnson & Johnson

premium

Buy

premium

Reiterated

2021-07-22

RHHBYRoche Holding AG

premium

Buy

premium

Initiated

2021-07-22

MRKMerck & Company

premium

Buy

premium

Assigned

2021-07-29

PFEPfizer Inc

premium

Hold

premium

Reiterated

2021-07-29

PFEPfizer Inc

premium

Hold

premium

Reiterated

2021-07-29

PFEPfizer Inc

premium

Hold

premium

Reiterated

2021-07-28

PFEPfizer Inc

premium

Hold

premium

Assigned

2021-07-28

All Ratings >

Most Recent Earnings of Healthcare Stocks

PFEPfizer

Jul 28, 2021

2021 (Q2)

0.97 / 0.98

0.61

60.66% (+0.37)

NVSNovartis

Jul 21, 2021

2021 (Q2)

1.55 / -

0.821

―

MRKMerck & Company

Jul 29, 2021

2021 (Q2)

1.31 / -

1.184

―

JNJJohnson & Johnson

Jul 21, 2021

2021 (Q2)

2.29 / 2.35

1.36

72.79% (+0.99)

RHHBYRoche Holding

Jul 22, 2021

2021 (Q2)

1.37 / -

1.223

―

Healthcare Stocks - FAQ

Which Healthcare stocks have a "Strong Buy" analyst rating?

These Healthcare stocks currently have a "Strong Buy" analyst rating consensus:

Johnson & Johnson - Strong Buy, based on 8 analyst ratings, 7 Buy, 1 Hold, and 0 Sell.

Are Healthcare stocks overpriced?

Pfizer's stock price is currently $42.81, and its average 12-month price target is $44.36.

Novartis's stock price is currently $92.39, and its average 12-month price target is $92.35.

Merck & Company's stock price is currently $76.87, and its average 12-month price target is $93.57.

Johnson & Johnson's stock price is currently $172.20, and its average 12-month price target is $190.86.

Roche Holding's stock price is currently $48.26, and its average 12-month price target is N/A.

Which Healthcare stocks pay dividends?

Pfizer does not currently pay dividends.

Novartis does not currently pay dividends.

Merck & Company currently pays a dividend of $0.65 which represents an annual dividend yield of 3.30%. Merck & Company's next Ex-dividend date is September 14, 2021 and its next payout date is October 7, 2021.

Johnson & Johnson currently pays a dividend of $1.06 which represents an annual dividend yield of 2.41%. Johnson & Johnson's next Ex-dividend date is August 23, 2021 and its next payout date is September 7, 2021.

Roche Holding does not currently pay dividends.